Shivani Agarwal, MD, MPH, is Director of the Supporting Emerging Adults with Diabetes (SEAD) program at Montefiore and an Assistant Professor of Medicine at our Albert Einstein College of Medicine. She is board-certified in Internal Medicine and Adult Endocrinology by the American Board of Internal Medicine. Since joining the Montefiore team in 2018, her clinical focus has been on the treatment of type 1 and type 2 diabetes in patients aged 18 to 35 years old.
In 2001, Dr. Agarwal received her Bachelor of Arts in Neuroscience at Wellesley College. From 2005 to 2010, she attended New York University School of Medicine where she received her Doctor of Medicine. During this time, Dr. Agarwal also attended Johns Hopkins Bloomberg School of Public Health pursuing her Master of Public Health degree, which she received in 2009.
Dr. Agarwal began her postgraduate training in 2010 with a yearlong internship in Internal Medicine at Columbia University College of Physicians and Surgeons. She continued to train at this institution and completed a residency in Internal Medicine in 2013. Following this, in 2015, Dr. Agarwal completed a fellowship in Endocrinology at the University of Pennsylvania, followed by a postdoctoral research fellowship in 2016.
Extending from her clinical focus, Dr. Agarwal’s research concentrates on clinical and behavioral interventions in young adults with type 1 diabetes, as well as racial and socioeconomic disparities in type 1 diabetes. She is funded by the NIH-NIDDK, Type 1 Diabetes Exchange, and Helmsley Charitable Trust. She has presented her work at symposia talks at the American Diabetes Association and grand rounds at outside institutions. She serves on the American Diabetes Association Healthcare Disparities Committee, and the Endocrine Society’s Innovative Models in Diabetes Care Task Force as well as the Advocacy and Public Outreach Core Committee (APOCC). Her work has been published in a number of peer-reviewed journals and book chapters. She has received several awards by the Helmsley Charitable Trust for her research and is an active member of the Type 1 Diabetes Exchange and SEARCH for Diabetes in Youth Consortium.
Dr. Agarwal led several pioneering research projects related to COVID-19 and diabetes, which have garnered enthusiasm and support from across the country, and are ongoing. These projects include the development and implementation of a COVID-19 subcutaneous DKA protocol; off-label use of continuous glucose monitors (CGM) in COVID-19 patients in the ICU; and several retrospective analyses of risk factors for mortality in patients with diabetes and COVID-19. She has spoken as a COVID-19 and diabetes expert on numerous national and international forums, including the American Diabetes Association COVID-19 webinar series; NY-Regional Center for Translational Research webinar series; Medscape invited talk at the American Diabetes Association; Hospital Diabetes Meeting of the Diabetes Technology Society; and the Annual Meeting of the Association of Diabetes Care and Education Specialists (formerly AADE). Her work and commentaries on diabetes and COVID-19 have been featured on UptoDate in the article on Diabetic Ketoacidosis and the American Diabetes Association COVID-19 website, COVID-IN-DIABETES (Collaborative OpenAccess Virtually Individualized Decision-Algorithms for Inpatient Diabetes (covidindiabetes.org), and Newsday.